Abano Healthcare Group Limited

Link copied
Case Copied 13 min read

IN THE HIGH COURT OF NEW ZEALAND AUCKLAND REGISTRY

I TE KŌTI MATUA O AOTEAROA TĀMAKI MAKAURAU ROHE

CIV-2020-404-1915

[2020] NZHC 3343

UNDER Part 19 of the High Court Rules

IN THE MATTER

of a scheme of arrangement under Part 15 of the Companies Act 1993

IN THE MATTER

of ABANO HEALTHCARE GROUP LIMITED

Applicant

Hearing: 9 December 2020

Counsel:

DJ Cooper and NW Starrenburg for applicant

JQ Wilson and JP Cooney for Adams NZ Bidco Limited

Judgment:

9 December 2020

Reasons:

16 December 2020


REASONS FOR JUDGMENT OF FITZGERALD J


This judgment was delivered by me on 16 December 2020 at 12 noon, pursuant to Rule 11.5 of the High Court Rules.

Registrar/Deputy Registrar

Date……………

Solicitors:           Harmos Horton Lusk, Auckland

Bell Gully, Auckland

Re Abano Healthcare Group Limited [2020] NZHC 3343 [16 December 2020]

Introduction

[1]    On 9 December 2020, I granted final orders approving a scheme of arrangement under Part 15 of the Companies Act 1993 (the Act). Those orders were in the following terms:

(a)The scheme of arrangement described in the Scheme Plan annexed to this order (the “Scheme”) is approved and binding upon:

(i)Abano Healthcare Group Limited;

(ii)Adams NZ Bidco Limited; and

(iii)Every person who is a Scheme Shareholder in terms of the Scheme Plan.

(b)Abano is granted leave to apply to the Court for approval of any amendment, modification or supplement to the Scheme.

[2]This judgment provides my reasons for making the above orders.

The parties

Abano

[3]    The applicant (Abano) was incorporated in New Zealand on 1 August 1961 as New Zealand Petroleum Company Limited, and listed on the NZX in January 1970. In 1999, the company’s name was changed to Eldercare New Zealand Limited (as it focused on the development of retirement village properties and aged care services). In 2003, the company was renamed Abano, reflecting its move towards a multi- discipline approach in healthcare and medical services. In 2008, Abano entered the Australian dental market and in 2017 sold its shareholding in Ascot Radiology to focus solely on the trans-Tasman dental market.

[4]    Abano operates through two brands: Lumino The Dentists (Lumino) in New Zealand and Maven Dental Group (Maven) in Australia. Its corporate office is in central Auckland.

[5]As of 31 August 2020, Abano had 228 dental practices, with:

(a)121 Lumino practices; and

(b)107 Maven practices.

[6]    Abano engages over 2,030 staff or contractors across New Zealand and Australia.

[7]    At the time the application for approval of the proposed Scheme of Arrangement (Scheme) was filed, Abano had 26,282,238 ordinary shares on issue (“Shares”) and as at 4 September 2020, there were 3,382 registered shareholders. All Shares are fully paid ordinary shares. At the time the application was filed, there were no shareholders that had a relevant interest in 5 per cent or more of the Shares.

[8]    Abano’s Shares are widely held by institutional and retail investors either directly or through custodial services. The top 20 shareholders as at 30 September 2020 together accounted for 45 per cent of the…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Abano Healthcare Group Limited and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2020] NZHC 3343
Decision Date

CaseChat Overview and Summary

The High Court of New Zealand was called upon to approve a scheme of arrangement under Part 15 of the Companies Act 1993 involving Abano Healthcare Group Limited (Abano) and Adams NZ Bidco Limited (Bidco). The primary legal issue was whether the scheme met the statutory requirements for approval under the Act, including whether it was fairly presented to shareholders, whether shareholders were adequately represented, and whether the scheme was fair and equitable. The court also needed to consider whether the scheme complied with the Takeovers Code, given it would affect the voting rights of a code company. The key facts were that Abano, a dental services provider operating in Australia and New Zealand, proposed a scheme whereby Bidco would acquire all of Abano's shares for $5.20 per share, subject to a cap of $0.75 per share in reductions if certain 'Adjustment Events' occurred. The court found that the scheme complied with statutory requirements, was fairly presented to shareholders, and that shareholders were fairly represented at the meeting where the scheme was approved by 95.40% of votes cast. The court also found that the scheme was fair and equitable, with the base consideration of $5.20 per share representing a 99% premium to Abano's share price prior to the scheme being announced. The court approved the scheme, allowing the acquisition to proceed.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.